Michael Cartwright to Oligonucleotides
This is a "connection" page, showing publications Michael Cartwright has written about Oligonucleotides.
Connection Strength
1.566
-
Cartwright MS, Upadhya S. Selecting disease-modifying medications in 5q spinal muscular atrophy. Muscle Nerve. 2021 Oct; 64(4):404-412.
Score: 0.789
-
Cartwright MS, Ward ZT, White EP, West TG. Intrathecal delivery of nusinersen in individuals with complicated spines. Muscle Nerve. 2020 07; 62(1):114-118.
Score: 0.726
-
Elman L, Youn B, Proud CM, Frey MR, Ajroud-Driss S, McCormick ME, Michelson D, Cartwright MS, Heiman-Patterson T, Choi JM, Chandak A, Khachatryan A, Martinez M, Paradis AD. Real-world Adherence to Nusinersen in Adults with Spinal Muscular Atrophy in the US: A Multi-site Chart Review Study. J Neuromuscul Dis. 2022; 9(5):655-660.
Score: 0.051